The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RESILIENT: Study of irinotecan liposome injection (nal-IRI) in patients with small cell lung cancer—Preliminary findings from part 1 dose-defining phase.
 
Luis G. Paz-Ares
Leadership - European Medicines Agency (I); Genomica
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Incyte; Lilly; Merck Serono; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sysmex
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca Spain; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
David R. Spigel
Leadership - TriStar Centennial Medical Center
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Evelo Therapeutics (Inst); Foundation Medicine (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Precision Oncology (Inst); Takeda (Inst); TRM Oncology (Inst)
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Aeglea Biotherapeutics (Inst); Amgen (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Foundation Medicine (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Nektar (Inst); Neon Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Pfizer (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Genzyme; Intuitive Surgical; Lilly; Merck; Pfizer; Purdue Pharma; Spectrum Pharmaceuticals; Sysmex
 
Christoph Zielinski
Consulting or Advisory Role - ARIAD; AstraZeneca; BMS Brazil; Boehringer Ingelheim; FibroGen; Imugene; Merck KGaA; MSD; Novartis; Roche
 
Yuanbin Chen
Honoraria - Array BioPharma; AstraZeneca; BMS Brazil; Genentech; Guardant Health; HERON; Lilly; Merck; Novartis; Pfizer
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genentech; HERON; Lilly; Novartis; Pfizer; Takeda
Speakers' Bureau - AstraZeneca; BMS Brazil; Genentech; Guardant Health; Lilly; Merck; Novartis; Takeda
Research Funding - AstraZeneca; BMS Brazil; Guardant Health; Helsinn Healthcare; Ipsen; Roche
Expert Testimony - AstraZeneca; Takeda
 
Maria Jove
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - BMS Brazil; MSD; Roche
 
Oscar Juan Vidal
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Research Funding - AstraZeneca Spain (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck Sharp & Dohme; Roche/Genentech
 
David Chu
Research Funding - AstraZeneca; Daiichi Sankyo; Ipsen; Pfizer
 
Patricia Rich
No Relationships to Disclose
 
Theresa M. Hayes
No Relationships to Disclose
 
M Vanesa Gutierrez Calderon
No Relationships to Disclose
 
Reyes Bernabe Caro
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Alejandro Navarro
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche
Expert Testimony - Oryzon Genomics
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer
 
Afshin Dowlati
Consulting or Advisory Role - Abbvie/Stemcentrx; ARIAD
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Lilly/ImClone (Inst); MedImmune (Inst); OncoMed (Inst)
 
Bin Zhang
Employment - Ipsen
 
Yan Moore
Employment - Ipsen
 
Haofei Tiffany Wang
Employment - Ipsen
 
Natalya Nazarenko
Employment - Ipsen
 
Santiago Ponce Aix
Consulting or Advisory Role - Roche
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - NS Pharma
 
Paul A. Bunn
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Merck Serono
Research Funding - Genentech (Inst)